Further reverse transcription quantitative polymerase chain reaction (RT-qPCR) validation in larger sample size identified 3 circRNAs (circ-PTK2, circ-RNF217 and circ-AFF2) that were potential biomarkers for MM risk as well as prognosis (7). The gene discussed is PTK2; the disease is Miyoshi myopathy.